GSK3A | Glycogen synthase kinase 3 alpha | Cancer-related genes Enzymes
| | | | | Expressed in all |
GSK3B | Glycogen synthase kinase 3 beta | Enzymes
| | | | | Expressed in all |
HIPK2 | Homeodomain interacting protein kinase 2 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
HIPK3 | Homeodomain interacting protein kinase 3 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
IKBKB | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | Disease related genes Enzymes FDA approved drug targets Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
IKBKE | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | Enzymes
| | | | | Mixed |
ILK | Integrin-linked kinase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
INSR | Insulin receptor | CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Expressed in all |
IRAK1 | Interleukin-1 receptor-associated kinase 1 | Enzymes
| | | | | Expressed in all |
IRAK4 | Interleukin-1 receptor-associated kinase 4 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
LATS2 | Large tumor suppressor kinase 2 | Enzymes
| | | | | Expressed in all |
LIMK1 | LIM domain kinase 1 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
LMTK2 | Lemur tyrosine kinase 2 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
LRRK1 | Leucine-rich repeat kinase 1 | Enzymes
| | | | | Mixed |
MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAP2K6 | Mitogen-activated protein kinase kinase 6 | Cytoskeleton related proteins Enzymes
| | | | | Expressed in all |
MAP3K2 | Mitogen-activated protein kinase kinase kinase 2 | Enzymes
| | | | | Expressed in all |
MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | Enzymes
| | | | | Expressed in all |
MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 | Enzymes Plasma proteins
| | | | | Expressed in all |
MAP3K9 | Mitogen-activated protein kinase kinase kinase 9 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Mixed |
MAP4K5 | Mitogen-activated protein kinase kinase kinase kinase 5 | Enzymes
| | | | | Expressed in all |
MAPK1 | Mitogen-activated protein kinase 1 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
MAPK12 | Mitogen-activated protein kinase 12 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Tissue enriched |
MAPK14 | Mitogen-activated protein kinase 14 | Cancer-related genes Enzymes
| | | | | Expressed in all |
MAPK3 | Mitogen-activated protein kinase 3 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAPK6 | Mitogen-activated protein kinase 6 | Enzymes
| | | | | Expressed in all |
MAPK7 | Mitogen-activated protein kinase 7 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MAPKAPK2 | Mitogen-activated protein kinase-activated protein kinase 2 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Expressed in all |
MAPKAPK3 | Mitogen-activated protein kinase-activated protein kinase 3 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
MAPKAPK5 | Mitogen-activated protein kinase-activated protein kinase 5 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
MAST2 | Microtubule associated serine/threonine kinase 2 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Expressed in all |
MASTL | Microtubule associated serine/threonine kinase-like | Disease related genes Enzymes Potential drug targets
| | | | | Mixed |
MET | Met proto-oncogene | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
MKNK2 | MAP kinase interacting serine/threonine kinase 2 | Enzymes
| | | | | Expressed in all |
MLTK | Mitogen-activated protein kinase kinase kinase MLT | Enzymes
| | | | | Expressed in all |
MST4 | Serine/threonine-protein kinase MST4 | Enzymes
| | | | | Mixed |
MYLK | Myosin light chain kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
NEK11 | NIMA-related kinase 11 | Enzymes
| | | | | Tissue enhanced |
NEK2 | NIMA-related kinase 2 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
NEK7 | NIMA-related kinase 7 | Enzymes
| | | | | Expressed in all |
NLK | Nemo-like kinase | Enzymes
| | | | | Expressed in all |
NTRK3 | Neurotrophic tyrosine kinase, receptor, type 3 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NUAK1 | NUAK family, SNF1-like kinase, 1 | Enzymes Plasma proteins
| | | | | Mixed |
OXSR1 | Oxidative stress responsive 1 | Enzymes
| | | | | Expressed in all |
PAK1 | P21 protein (Cdc42/Rac)-activated kinase 1 | Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PAK2 | P21 protein (Cdc42/Rac)-activated kinase 2 | Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PASK | PAS domain containing serine/threonine kinase | Enzymes
| | | | | Tissue enhanced |
PDIK1L | PDLIM1 interacting kinase 1 like | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
PDK2 | Pyruvate dehydrogenase kinase, isozyme 2 | Enzymes Mitochondrial proteins
| | | | | Expressed in all |